$PFE Pfizer Inc (PFE) 30.71 +0.02 (+0.07%) Past 5 Days
$PFE
Pfizer Inc (PFE)
30.71 +0.02 (+0.07%)
Past 5 Days
Date Open High Low Last Change % Change Volume
12/31/13 30.62 30.81 30.51 30.71 +0.02 +0.07% 3,768,155
12/30/13 30.54 30.70 30.39 30.69 +0.05 +0.16% 14,799,300
12/27/13 30.76 30.85 30.53 30.64 +0.09 +0.29% 11,958,400
12/26/13 30.37 30.56 30.32 30.55 +0.26 +0.86% 12,058,200
12/24/13 30.44 30.45 30.22 30.29 -0.06 -0.20% 10,992,399
Historical Highs and Lows
-- Period -- -- High -- -- Low -- -- Percent Change --
5-Day 30.85 on 12/27/13 30.32 on 12/26/13 +1.39% since 12/24/13
1-Month 31.93 on 12/02/13 29.95 on 12/13/13 -3.21% since 11/29/13
3-Month 32.50 on 11/25/13 28.02 on 10/09/13 +6.89% since 09/30/13
6-Month 32.50 on 11/25/13 27.33 on 07/03/13 +9.64% since 06/28/13
12-Month 32.50 on 11/25/13 24.63 on 12/31/12 +23.38% since 12/28/12
Year to Date 32.50 on 11/25/13 25.33 on 01/02/13 +22.45% since 12/31/12
New Highs and Lows
For The Last Made New High Percent From Made New Low Percent From
5-Day 2 times -0.45% 1 time +1.29%
1-Month 1 time -3.82% 6 times +2.54%
3-Month 15 times -5.51% 3 times +9.60%
6-Month 20 times -5.51% 3 times +12.37%
12-Month 38 times -5.51% 1 time +24.69%
Year to Date 37 times -5.51% 1 time +21.24%
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...
Continue Reading
A New Era of Strength Training Equipment? That's the question I asked myself when I heard about YR Fitness showcasing their latest gym gear at FIBO 2027. This isn't just another batch of machines rolling off the production line. YR Fitness has become quite the icon in China for strength equipment, and they're dead set on shaking up the market in Cologne, Germany from...
Continue Reading
The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...
Continue Reading
Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...
Continue Reading
Alfa Laval's Vision for the Future Alfa Laval is gearing up for a dynamic Capital Markets Day on November 18, 2026. The Swedish engineering giant, renowned for heat transfer, separation, and fluid handling solutions, is setting the stage to outline bold strategies and ambitious targets. Investors should pay attention, as the company's roadmap charts a course towards a SEK...
Continue Reading
A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...
Continue Reading
WareSpace's National Growth Strategy: A New Expansion Chapter They say everything's bigger in Texas, but WareSpace is showing that smaller can be mighty impactful too. With its shrewd acquisition of sites in Houston's Inner Loop and Fremont's Warm Springs corridor, WareSpace is playing it smart, appeasing that roaring demand for tiny but mighty warehouse spaces across...
Continue Reading
What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...
Continue Reading
Electric Pulse: Kia's Electrified Dreams Soar No one said the road to the top is easy, yet Kia America is cruising along with six straight months of shattering sales records. October's monumental figures paint the picture clear as a bell — 80,008 units dispatched to eager drivers, with electrified and hybrid models zooming to new heights. It ain't just the same old...
Continue Reading
In the ever-evolving world of supply chain technology, a big move by TEKLYNX is making waves. The 2026 version of their barcode labeling software isn't just an upgrade—it's a full-blown transformation. They've fine-tuned their suite to align with the latest industry standards and integrated fresh capabilities that scream future-proofing. TEKLYNX's Game-Changing Upgrades...
Continue Reading
Top 5 Most Recently Viewed Articles
Tsubame BHB Earns Recognition in Global Cleantech Innovation Tsubame BHB Co., Ltd. has recently made headlines for being named one of the standout companies in the 2025 Global Cleantech 100 list, an accolade that underscores its innovative approach to ammonia manufacturing. This recognition highlights the company's commitment to harnessing low-temperature and low-pressure...
Continue Reading
Smart Investment Growth: The Rise of Onto Innovation In the last five years, Onto Innovation (NYSE: ONTO) has emerged as a remarkable player in the stock market, significantly surpassing average market gains. With an impressive annualized return of 42.16%, those who invested in ONTO have experienced extraordinary growth. The Power of Compound Returns Understanding...
Continue Reading
Dr. Beatrice Setnik Honored as PharmaVoice 100 Winner Altasciences is thrilled to share that Dr. Beatrice Setnik has been honored as a PharmaVoice 100 winner. With almost two decades of expertise in clinical drug development, especially regarding abuse potential studies, Dr. Setnik's leadership qualities have made a notable impact in the field. As the Chief Scientific...
Continue Reading
Momentus Inc Achieves Significant Milestone Momentus Inc (NASDAQ: MNTS) has recently made headlines with a notable increase in its stock value after the company secured inclusion in a crucial defense contract program in the U.S. This achievement not only highlights the strategic importance of the company’s offerings but also brings in new opportunities for growth as...
Continue Reading
Exceptional Financial Results for HCI Group in Q2 2025 HCI Group, Inc. (NYSE:HCI) has reported outstanding financial performance for the second quarter of 2025, showcasing remarkable metrics that highlight its commitment to profitability and shareholder value. With a pre-tax income of $94.4 million and a net income of $70.3 million, up from $54.1 million in the second...
Continue Reading